ANI Pharmaceuticals (ANIP)
(Delayed Data from NSDQ)
$67.36 USD
+0.11 (0.16%)
Updated May 6, 2024 04:00 PM ET
After-Market: $67.37 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth B Momentum A VGM
Brokerage Reports
ANI Pharmaceuticals, Inc. [ANIP]
Reports for Purchase
Showing records 21 - 40 ( 88 total )
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
3Q16 Recap - Within Expectations, but Mix Shift Holding Back EBITDA
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
1Q16 Recap - Solid Quarter, New Launches Coming
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
3Q15 Recap - Valuation and Pipeline Should Offset Near-term Issues
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.